Early impact of COVID-19 on transplant center practices and policies in the United States
Brian J. Boyarsky(Johns Hopkins University), Jacqueline Garonzik‐Wang(University of Wisconsin–Madison), Teresa Po‐Yu Chiang(Johns Hopkins University), Allan B. Massie(Johns Hopkins University), Amber Kernodle(Brigham and Women's Hospital), Robin K. Avery(Johns Hopkins University), Sarah E. Van Pilsum Rasmussen(Johns Hopkins University), Kyle R. Jackson(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Samantha Getsin(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore)
Cited by 244
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
|Immunity|2012|707
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
|Journal of Clinical Oncology|1997|706